Dexlansoprazole group

DRUG2 trials

Sponsors

Kaohsiung Medical University Chung-Ho Memorial Hospital, Faculty of Medicine Siriraj Hospital, Mahidol University

Conditions

Gastroesophageal Reflux DiseaseHeartburn acid regurgitation NERD nonerosive esophageal reflux disease Heartburn acid regurgitation NERD nonerosive esophageal reflux disease

Phase 3

A Randomized Controlled Trial of Dexlansoprazole vs. Double Dose Omeprazole in Non-responsive Nonerosive Esophageal Reflux Disease

RecruitingTCTR20160517003

Faculty of Medicine Siriraj Hospital, Mahidol UniversityHeartburn acid regurgitation NERD nonerosive esophageal reflux disease Heartburn acid regurgitation NERD nonerosive esophageal reflux disease

Start: 2015-08-03Target: 118Updated: 2026-08-03

Phase 4

Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B

CompletedNCT03128736

Kaohsiung Medical University Chung-Ho Memorial HospitalGastroesophageal Reflux Disease

Start: 2014-04-01End: 2016-03-30Updated: 2017-04-25

Related Papers

<p>Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial</p>

Drug Design Development and Therapy2019-04-017 citations